Auvelity

Sunosi

- Sunosi Royalty

- Sunosi License Revenue

Total Revenue

fdbe3a802b2a88703a68ede5041aae567cb60feae5de77872fe7806f288d69b2

Net Loss (USD, thousands)

Stock-based Compensation Expense (USD, thousands)

Amortization of Intangible Asset (USD, thousands)

Amortization of Debt Discount (USD, thousands)

Depreciation (USD, thousands)

Loss in Fair Value of Contingent Consideration (USD, thousands)

Loss (Gain) in Fair Value of Contingent Consideration (USD, thousands)

Non-cash Lease Expense (USD, thousands)

Change in Operating Lease Liability (USD, thousands)

Net Cash Used in Operating Activities (USD, thousands)

Purchases of Equipment (USD, thousands)

Cash Paid for Business Combination (USD, thousands)

Net Cash Used in Investing Activities (USD, thousands)

Proceeds from Draw Down of Debt (USD, thousands)

Payment of Debt Issuance Costs (USD, thousands)

Payments on Principal Portion of Finance Lease Obligation (USD, thousands)

Proceeds from Issuance of Common Stock upon Financing (USD, thousands)

Cash Paid for Common Stock Issuance Costs (USD, thousands)

Proceeds from Issuance of Common Stock upon Exercise of Options and ESPP (USD, thousands)

Payment of Contingent Consideration (USD, thousands)

Payments of Tax Withholdings on Stock Awards (USD, thousands)

Net Cash Provided by Financing Activities (USD, thousands)

Net (Decrease) Increase in Cash (USD, thousands)

Interest Paid (USD, thousands)

Operating Lease Right-of-use Asset Obtained for Liability (USD, thousands)

Issuance of Warrants in Connection with Debt Financing (USD, thousands)

Accounts Receivable, Net (USD, thousands)

Inventories, Net (USD, thousands)

Prepaid Expenses and Other Current Assets (USD, thousands)

Non-current Inventory and Other Assets (USD, thousands)

Accounts Payable (USD, thousands)

Accrued Expenses and Other Current Liabilities (USD, thousands)

Cash at Beginning of Period (USD, thousands)

Cash at End of Period (USD, thousands)

Fair Value of Contingent Consideration in Business Combination (USD, thousands)

94210e05446cdcd70256cc14812d59131c1c13b405db682edea68087e5fc7ccf

Product Sales, Net (USD, thousands)

License Revenue (USD, thousands)

Royalty and Milestone Revenue (USD, thousands)

Total Revenues (USD, thousands)

Cost of Revenue (excl. Amortization & Depreciation) (USD, thousands)

Research and Development Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Gain in Fair Value of Contingent Consideration (USD, thousands)

Intangible Asset Amortization (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Interest Expense, Net (USD, thousands)

Loss Before Income Taxes (USD, thousands)

Income Tax Expense (USD, thousands)

Net Loss per Common Share, Basic and Diluted (USD)

Weighted Average Common Shares Outstanding, Basic and Diluted (shares)

9af34cb84d95fb2d346d8aca9a00e575f8d78915fc5a01efe786aebd7e7e5f44

United States

Outside of the United States

- Royalty Revenue

895338b19f021f6eb1512f5b4f5ddf62a6df82e453713a683dfbe9829a8fe18a

Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories, net (USD, thousands)

Prepaid and other current assets (USD, thousands)

Total current assets (USD, thousands)

Equipment, net (USD, thousands)

Right-of-use asset - operating lease (USD, thousands)

Goodwill (USD, thousands)

Intangible asset, net (USD, thousands)

Non-current inventory and other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Operating lease liability, current portion (USD, thousands)

Contingent consideration, current (USD, thousands)

Total current liabilities (USD, thousands)

Contingent consideration, non-current (USD, thousands)

Loan payable, long-term (USD, thousands)

Operating lease liability, long-term (USD, thousands)

Finance lease liability, long-term (USD, thousands)

Total liabilities (USD, thousands)

Common stock, $ 0.0001 par value per share (150,000,000 shares authorized, ...) (USD, thousands)

Axsome Therapeutics Inc (AXSM)

Financials